More importantly, miR-200a-3p combined with AFP showed effective predictive performance in the differential diagnosis between CHB/cirrhosis and HCC (AUC > 0.9) in the discovery and testing cohorts. This evidence concerns the gene AFP and hepatocellular carcinoma.